Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Axon Enterprise | AXON | 2. jul 2024 | 293.18 | +1.37 |
Baker Hughes A | BKR | 2. jul 2024 | 34.69 | -0.72 |
Ball | BALL | 2. jul 2024 | 59.71 | +0.27 |
Bank Of America | BAC | 2. jul 2024 | 40.93 | +2.30 |
Bank Of New York Mellon | BK | 2. jul 2024 | 60.50 | +0.65 |
Bath & Body Works | BBWI | 2. jul 2024 | 38.12 | -0.83 |
Baxter International | BAX | 2. jul 2024 | 32.85 | -0.64 |
Becton, Dickinson And Co | BDX | 2. jul 2024 | 229.24 | -0.01 |
Berkshire Hathaway B | BRK-B | 2. jul 2024 | 407.10 | +0.47 |
Best Buy | BBY | 2. jul 2024 | 82.17 | -0.15 |
Bio-Rad Laboratories A | BIO | 2. jul 2024 | 267.55 | +1.36 |
Bio-Techne | TECH | 2. jul 2024 | 71.24 | -0.52 |
Biogen | BIIB | 2. jul 2024 | 228.82 | -1.27 |
BlackRock | BLK | 2. jul 2024 | 789.13 | +0.88 |
Blackstone | BX | 2. jul 2024 | 123.21 | +0.80 |
Boeing | BA | 2. jul 2024 | 185.42 | -0.69 |
Booking | BKNG | 2. jul 2024 | 3 916.21 | +0.81 |
BorgWarner | BWA | 2. jul 2024 | 31.76 | +0.86 |
Boston Properties | BXP | 2. jul 2024 | 61.55 | +1.42 |
Boston Scientific | BSX | 2. jul 2024 | 76.55 | +0.18 |
Bristol-Myers Squibb | BMY | 2. jul 2024 | 40.45 | -2.06 |
Broadcom | AVGO | 2. jul 2024 | 1 657.48 | +1.02 |
Broadridge Financial Solutions | BR | 2. jul 2024 | 198.29 | +0.88 |
Brown & Brown | BRO | 2. jul 2024 | 89.65 | +0.61 |
Brown Forman B | BF-B | 2. jul 2024 | 42.48 | +0.88 |
Builders Firstsource | BLDR | 2. jul 2024 | 134.74 | +0.56 |
Bunge | BG | 2. jul 2024 | 110.38 | +2.85 |
Cadence Design Systems | CDNS | 2. jul 2024 | 316.78 | +1.88 |
Caesars Entertainment | CZR | 2. jul 2024 | 37.42 | -0.87 |
Camden Property Trust | CPT | 2. jul 2024 | 108.93 | -0.24 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.